Kwon, B. S., Park, J. H., Kim, S., Park, S., Ji, W., Kim, W. S., . . . Choi, C. (2019). Survival benefit of first-generation epidermal growth factor receptor-tyrosine kinase inhibitors in female with advanced lung cancer. Tumori, 105(3), p. 216. doi:10.1177/0300891619839292

Kwon, Byoung Soo, Ji Hyun Park, Seulgi Kim, Sojung Park, Wonjun Ji, Woo Sung Kim, Jae Cheol Lee, Yu Rang Park, and Chang-Min Choi. "Survival Benefit of First-generation Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Female With Advanced Lung Cancer." Tumori 105, no. 3 (2019): 216.

Kwon, Byoung Soo, et al. "Survival Benefit of First-generation Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Female With Advanced Lung Cancer." Tumori 105.3 (2019): 216.